glp 1 receptor agonist agent GLP-1 agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 medicines: Tirzepatide, Semaglutide, and

doi: 10.1016/j.cmet.2006.01.004 15 KimaniCNReuterHKotzSHMullerCJF

Now that we understand how exactly TMA is produced in the gut and that the enzyme can be inhibited, there are grounds for further research into future discovery of drugs targeting the TMA-producing enzyme in the human gut

That said, it is not a guaranteed solution, and responsible use requires education, medical oversight, and realistic expectations

Call us today and request the Super Shot

The Importance of Holistic Wellness While glutathione and collagen are powerful tools, they work best when they are part of a broader wellness strategy

In the future, it might be used for more intense therapies for cancer treatment and other conditions